Zakani Ltd Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: NI628620

ZAKANI LTD

FILLETED UNAUDITED FINANCIAL STATEMENTS

31 March 2025

ZAKANI LTD

FINANCIAL STATEMENTS

YEAR ENDED 31 MARCH 2025

Contents	Page

Officers and professional advisers	1

Statement of financial position	2

Notes to the financial statements	4

ZAKANI LTD

OFFICERS AND PROFESSIONAL ADVISERS

Director	Mr R Smith

Registered office	13 Fifth Ave
	Bangor
	Co. Down
	Northern Ireland
	BT20 5JP

Accountants	FEB Chartered Accountants
	Chartered Accountants
	Linenhall Exchange
	1st Floor,
	26 Linenhall Street
	Belfast
	Northern Ireland
	BT2 8BG

ZAKANI LTD

STATEMENT OF FINANCIAL POSITION

31 March 2025

	2025	2024
Note	£	£

Fixed assets

Investments	6	100	100

Current assets

Debtors	7	1,913,548	1,357,440
Cash at bank and in hand		51,498	37,854
		------------	------------
		1,965,046	1,395,294

Creditors: amounts falling due within one year	8	11,165	34,542
		------------	------------
Net current assets		1,953,881	1,360,752
		------------	------------
Total assets less current liabilities		1,953,981	1,360,852

Creditors: amounts falling due after more than one year	9	4,334	9,548
		------------	------------
Net assets		1,949,647	1,351,304
		------------	------------

Capital and reserves

Called up share capital	10	1	1
Profit and loss account		1,949,646	1,351,303
		------------	------------
Shareholders funds		1,949,647	1,351,304
		------------	------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

ZAKANI LTD

STATEMENT OF FINANCIAL POSITION (continued)

31 March 2025

These financial statements were approved by the board of directors and authorised for issue on 22 December 2025 , and are signed on behalf of the board by:

Mr R Smith
Director

Company registration number: NI628620

ZAKANI LTD

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 MARCH 2025

1. General information

The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is 13 Fifth Ave, Bangor, Co. Down, BT20 5JP, Northern Ireland.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

Covid-19

Since 31 December 2019, the spread of Covid-19 has severely impacted many economies around the globe. Measures taken to contain the spread of the virus, including travel bans and quarantines, have triggered significant disruptions to businesses worldwide. It is not possible to reliably estimate the duration and severity of these consequences on the financial position of the company however the directors believe there will be no impact on the companies ability to continue as a going concern.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable services rendered, stated net of discounts and of Value Added Tax. When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period. When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable. Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Fixtures and fittings	-	20% straight line
Equipment	-	20% straight line

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Investments in associates

Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.

Investments in joint ventures

Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).

5. Tangible assets

	Fixtures and fittings	Equipment	Total
	£	£	£
Cost
At 1 April 2024 and 31 March 2025	1,145	1,030	2,175
	-------	-------	-------
Depreciation
At 1 April 2024 and 31 March 2025	1,145	1,030	2,175
	-------	-------	-------
Carrying amount
At 31 March 2025	–	–	–
	-------	-------	-------
At 31 March 2024	–	–	–
	-------	-------	-------

6. Investments

	Shares in group undertakings
	£
Cost
At 1 April 2024 and 31 March 2025	100
	----
Impairment
At 1 April 2024 and 31 March 2025	–
	----

Carrying amount
At 31 March 2025	100
	----
At 31 March 2024	100
	----

Zakani Ltd sold it's 50% share in AKM Developments Limited on 31 August 2021.

7. Debtors

	2025	2024
	£	£
Amounts owed by group undertakings	1,013,216	853,651
Other debtors	900,332	503,789
	------------	------------
	1,913,548	1,357,440
	------------	------------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£
Amounts owed to group undertakings	5,699	6,427
Corporation tax	–	22,859
Other creditors	5,466	5,256
	--------	--------
	11,165	34,542
	--------	--------

9. Creditors: amounts falling due after more than one year

	2025	2024
	£	£
Bank loans and overdrafts	4,334	9,548
	-------	-------

10. Called up share capital

Issued, called up and fully paid

	2025		2024
	No.	£	No.	£
Ordinary shares of £ 1 each	1	1	1	1
	----	----	----	----

11.

12. Related party transactions

The company was under the control of Mr R Smith , as sole director and shareholder, throughout the current and previous year. Transactions with directors are disclosed in note 11 of the financial statements. Mr Smith is also a director and shareholder of Bayrock Capital Ltd. During the year, the company advanced net loans of £nil (2024: £nil) to Bayrock Capital Ltd. At the balance sheet date, £107,250 (2024: £107,250) remained owing to the company. Mr Smith is also a director and shareholder of Anvari Partners Ltd. During the year, the company advanced net loans of £7,000 (2024: £43,000) to Anvari Partners Ltd. At the balance sheet date, £303,475 (2024: £296,475) remained owing to the company. Mr Smith is also a director and shareholder of Ambly Ltd. During the year, the company advanced net loans of £NIl (2024: £Nil) to Ambly Ltd. At the balance sheet date, £77,603 (2024: £77,603) remained owing to the company. The company is a shareholder of Dunluce Healthcare Ltd and Dunluce Capital Management Ltd. At the balance sheet date, £5,698 (2024: £6,428) remained owing to Dunluce Healthcare Ltd and £nil (2024: £nil) to Dunluce Capital Management Ltd.